Therapeutic potential of alternative splicing in cardiovascular diseases
eBioMedicine · 2024-03 · 101 · 104995
DOI: 10.1016/j.ebiom.2024.104995 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift eBioMedicine, 2024-03. Verfasst von Jun Cao und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Life Science, Beijing University of Technology, Beijing, 100124, PR China; University of Texas Medical Branch at Galveston, …. Hauptthemen laut MEDLINE: Alternative Splicing, Cardiovascular Diseases. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Natural Science Foundation, Beijing Municipal Natural Science Foundation, National Key Research and Development Program of China.
Abstract (Originalsprache)
RNA splicing is an important RNA processing step required by multiexon protein-coding mRNAs and some noncoding RNAs. Precise RNA splicing is required for maintaining gene and cell function; however, mis-spliced RNA transcripts can lead to loss- or gain-of-function effects in human diseases. Mis-spliced RNAs induced by gene mutations or the dysregulation of splicing regulators may result in frameshifts, nonsense-mediated decay (NMD), or inclusion/exclusion of exons. Genetic animal models have characterised multiple splicing factors required for cardiac development or function. Moreover, sarcomeric and ion channel genes, which are closely associated with cardiovascular function and disease, are hotspots for AS. Here, we summarise splicing factors and their targets that are associated with cardiovascular diseases, introduce some therapies potentially related to pathological AS targets, and raise outstanding questions and future directions in this field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Life Science, Beijing University of Technology, Beijing, 100124, PR China; University of Texas Medical Branch at Galveston, TX, 77555, USA.
- Department of Biochemistry & Molecular Biology, State Key Laboratory of Common Mechanism Research for Major Diseases, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical Colle…
- State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China. Electronic addres…
Förderung
- Beijing Natural Science Foundation
- Beijing Municipal Natural Science Foundation
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Cao, J., Wei, Z., Nie, Y., & Chen, H. Z. (2024). Therapeutic potential of alternative splicing in cardiovascular diseases. eBioMedicine, 101, 104995. https://doi.org/10.1016/j.ebiom.2024.104995
Vancouver
Cao J, Wei Z, Nie Y, Chen HZ. Therapeutic potential of alternative splicing in cardiovascular diseases. eBioMedicine. 2024;101:104995. doi:10.1016/j.ebiom.2024.104995
BibTeX
@article{Cao2024,
author = {Cao, Jun and Wei, Ziyu and Nie, Yu and Chen, Hou-Zao},
title = {Therapeutic potential of alternative splicing in cardiovascular diseases},
journal = {eBioMedicine},
year = {2024},
volume = {101},
pages = {104995},
doi = {10.1016/j.ebiom.2024.104995}
}
EUVIMED